Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa (IMPROVE)
Phase 3
- Conditions
- MalariaSexually Transmitted and Reproductive Tract Infections in Pregnancy
- Registration Number
- PACTR202005615501026
- Lead Sponsor
- iverpool School of Tropical Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 4680
Inclusion Criteria
Pregnant women between 16-28 weeks' gestation
Viable singleton pregnancy
Resident of the study area
Willing to adhere to scheduled and unscheduled study visit procedures
Willing to deliver in a study clinic or hospital
Provide written informed consent
Exclusion Criteria
Multiple pregnancies (i.e. twin/triplets)
HIV-positive
Known heart ailment
Severe malformations or non-viable pregnancy if observed by ultrasound
History of receiving IPTp-SP during this current pregnancy
Unable to give consent
Known allergy or contraindication to any of the study drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method